STEMRIM |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 457 JPY | -2.35% |
|
-2.98% | -21.11% |
| 09/05 | StemRIM to Seek Shareholders' Approval on Capital Stock Reduction | MT |
| 13/03 | StemRIM Announces Initiation of Phase 2 Clinical Trial for Redasemtide in Ischemic Cardiomyopathy | CI |
Press Releases
- Stock Market
- Equities
- 4599 Stock
- News StemRIM
- Press Releases
